CL2004002016A1 - THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEAST - Google Patents
THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEASTInfo
- Publication number
- CL2004002016A1 CL2004002016A1 CL2004002016A CL2004002016A CL2004002016A1 CL 2004002016 A1 CL2004002016 A1 CL 2004002016A1 CL 2004002016 A CL2004002016 A CL 2004002016A CL 2004002016 A CL2004002016 A CL 2004002016A CL 2004002016 A1 CL2004002016 A1 CL 2004002016A1
- Authority
- CL
- Chile
- Prior art keywords
- abuse
- optionally
- proof
- dosage form
- auxiliary substances
- Prior art date
Links
Abstract
LA PRESENTE INVENCION SE REFIERE A UNA FORMA DE DOSIFICACION TERMOFORMADA MEDIANTE EXTRUSION SIN DECOLORACION A PRUEBA DE ABUSO QUE CONTIENE ADEMAS, DE UNOS O MAS PRINCIPIOS ACTIVOS SUSCEPTIBLES DE ABUSO Y OPCIONALMENTE SUSTANCIAS AUXILIARES FISIOLOGICAMENTE ACEPTABLES, AL MENOS UN POLIMERO SINTETICO O NATURAL CON UNA DUREZA DE AL MENOS 500 N Y UN PROCESO DE PREPARACION DE LA MISMA.THE PRESENT INVENTION REFERS TO A THERMOFORMED DOSAGE FORM THROUGH EXTRUSION WITHOUT PROOF OF ABUSE THAT CONTAINS IN ADDITION, OF ONE OR MORE PRINCIPLES OF SUSCEPTIBLE ABUSE AND OPTIONALLY PHYSIOLOGICALLY UNDERLY NATURALLY ACCEPTED SUBSTANCES AT LEAST 500 NY A PREPARATION PROCESS OF THE SAME.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10336400A DE10336400A1 (en) | 2003-08-06 | 2003-08-06 | Anti-abuse dosage form |
DE10361596A DE10361596A1 (en) | 2003-12-24 | 2003-12-24 | Process for producing an anti-abuse dosage form |
DE102004020220A DE102004020220A1 (en) | 2004-04-22 | 2004-04-22 | Process for the preparation of a secured against misuse, solid dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004002016A1 true CL2004002016A1 (en) | 2005-05-20 |
Family
ID=40261417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2004002016A CL2004002016A1 (en) | 2003-08-06 | 2004-08-06 | THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEAST |
Country Status (1)
Country | Link |
---|---|
CL (1) | CL2004002016A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9629807B2 (en) | 2003-08-06 | 2017-04-25 | Grünenthal GmbH | Abuse-proofed dosage form |
US9636303B2 (en) | 2010-09-02 | 2017-05-02 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
US9737490B2 (en) | 2013-05-29 | 2017-08-22 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
US9750701B2 (en) | 2008-01-25 | 2017-09-05 | Grünenthal GmbH | Pharmaceutical dosage form |
US10058548B2 (en) | 2003-08-06 | 2018-08-28 | Grünenthal GmbH | Abuse-proofed dosage form |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
US10080721B2 (en) | 2009-07-22 | 2018-09-25 | Gruenenthal Gmbh | Hot-melt extruded pharmaceutical dosage form |
US10130591B2 (en) | 2003-08-06 | 2018-11-20 | Grünenthal GmbH | Abuse-proofed dosage form |
US10154966B2 (en) | 2013-05-29 | 2018-12-18 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
US10201502B2 (en) | 2011-07-29 | 2019-02-12 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
US10300141B2 (en) | 2010-09-02 | 2019-05-28 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
US10369109B2 (en) | 2002-06-17 | 2019-08-06 | Grünenthal GmbH | Abuse-proofed dosage form |
-
2004
- 2004-08-06 CL CL2004002016A patent/CL2004002016A1/en unknown
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10369109B2 (en) | 2002-06-17 | 2019-08-06 | Grünenthal GmbH | Abuse-proofed dosage form |
US9629807B2 (en) | 2003-08-06 | 2017-04-25 | Grünenthal GmbH | Abuse-proofed dosage form |
US10130591B2 (en) | 2003-08-06 | 2018-11-20 | Grünenthal GmbH | Abuse-proofed dosage form |
US10058548B2 (en) | 2003-08-06 | 2018-08-28 | Grünenthal GmbH | Abuse-proofed dosage form |
US9750701B2 (en) | 2008-01-25 | 2017-09-05 | Grünenthal GmbH | Pharmaceutical dosage form |
US10080721B2 (en) | 2009-07-22 | 2018-09-25 | Gruenenthal Gmbh | Hot-melt extruded pharmaceutical dosage form |
US10300141B2 (en) | 2010-09-02 | 2019-05-28 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
US9636303B2 (en) | 2010-09-02 | 2017-05-02 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
US10201502B2 (en) | 2011-07-29 | 2019-02-12 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
US10864164B2 (en) | 2011-07-29 | 2020-12-15 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
US9737490B2 (en) | 2013-05-29 | 2017-08-22 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
US10154966B2 (en) | 2013-05-29 | 2018-12-18 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2004002017A1 (en) | THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE ABUSE PRINCIPLES, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A SYNTHETIC OR NATURAL POLYMER OF A DEFINED GROUP AND (D) OPTIONAL | |
AR045353A1 (en) | ABUSE PROOF DOSAGE FORM | |
AR046994A1 (en) | PROCESS FOR THE PRODUCTION OF AN ABUSE PROOF DOSAGE FORM | |
CL2004002016A1 (en) | THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEAST | |
UY28509A1 (en) | DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
DE60206137D1 (en) | HERBAL PLANTS CONTAINING MEDICINAL PRODUCTS | |
CY1111458T1 (en) | DOSAGE FORMS OF GENERAL LINEAR, ANAVARASUS, ORAL FENTANYL AND METHODS OF ADMINISTRATION | |
ES2169087T3 (en) | ORAL FORMULATIONS OF AN ANTIFUNGIC. | |
DK1501534T5 (en) | Desmopressin in orodispersible dosage form | |
DE60327103D1 (en) | PHARMACEUTICAL FORMS CONTAIN A PROTON PUMP, A NAZID AND A BUFFER | |
ITRM20000520A0 (en) | COSMETIC FORMULATION. | |
ATE354362T1 (en) | STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHIC ACTIVE INGREDIENT | |
UY27296A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING MOSAPRIDE AND PANCREATIN | |
UY27929A1 (en) | PHARMACEUTICAL COMPOSITIONS OF SEMIORDENED AND POLYMER DRUGS | |
ATE307845T1 (en) | N-ALKYLAZIRIDINOPREPOLYMERS AS DENTAL MATERIAL | |
DE60102590T2 (en) | PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
BR0115775B1 (en) | a package comprising a container and a membrane. | |
AR039232A1 (en) | A PHARMACEUTICAL FORMULATION THAT INCLUDES AT LEAST A SELECTED COMPOSITE OF THE GROUP FORMED BY NON-BARBITURIC HYPNOTICS AND NON-BENZODIACEPINICS, AND MELATONIN | |
BR0015198A (en) | Combination of device and packaging of tooth staining, and, matrix | |
ATE410154T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING 2,4-DICHLOROBENZYL ALCOHOL AND AMYLMETACRESOL | |
AR038560A1 (en) | AN ANTITRANSPIRANT / DEODORANT COMPOSITION | |
CR8619A (en) | PARASITICIATED AGENTS | |
SE0001916D0 (en) | Novel formulation | |
SE0203817D0 (en) | New composition |